Indianapolis, IN, United States of America

Gary A Koppel

This inventor holds 50 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Neurotherapeutics (CPC class 2602). Top assignees: Eli Lilly and Company, Revaax Pharmaceuticals, LLC, Azevan Pharmaceuticals, Inc.. Active years: 1976-2017.

USPTO Granted Patents = 50 (Patent Applications = 7)

% Patents Active = 90.0

CIPO Patents = 2

EPO Patents = 3

Average Co-Inventor Count = 1.8

ph-index = 12

Forward Citations = 486(Granted Patents)

Forward Citations (Not Self Cited) = 447(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

37 out of 4,508

Eli Lilly and Company

patents

8 out of 8

Revaax Pharmaceuticals, LLC

patents

5 out of 12

Azevan Pharmaceuticals, Inc.

patents

Years Active: 1976-2017

Loading Chart...

Areas of Expertise:

Vasopressin Antagonists

Neurotherapeutic Treatment

Sexual Dysfunction

Beta-Lactam Compounds

Antibody Drug-Conjugates

Azetidinone Antibiotics

Cannabinoid Receptor Antagonists

Immunoglobulin Conjugates

Angiogenesis

Cephalosporin Ethers

Behavioral Disorders

Carboxypeptidase Inhibitors

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9597314 - Beta-lactamylalkanoic acids for treating premenstrual disorders (2017-03-21),

2. 8426400 - β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists (2013-04-23),

3. 8048874 - Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists (2011-11-01),

4. 7998991 - Neurotherapeutic treatment for sexual dysfunction (2011-08-16),

5. 7842683 - Neurotherapeutic compositions and method (2010-11-30),

6. 7833998 - Oral neurotherapeutic cephalosporin sulfoxide and sulfone-containing compositions (2010-11-16),

7. 7268125 - [object Object] (2007-09-11),

8. 7166626 - Therapeutic treatment for sexual dysfunction (2007-01-23),

9. 7119083 - [object Object] (2006-10-10),

10. 6627625 - Treatment of behavioral disorders with &bgr;-lactam compounds (2003-09-30),

11. 6610681 - Neurotherapeutic clavulanate composition and method (2003-08-26),

12. 6610680 - Non-peptidyl vasopressin V1A antagonists (2003-08-26),

13. 6521611 - Non-peptidyl vasopressin V1a antagonists (2003-02-18),

14. 6489319 - Neurotherapeutic use of carboxypeptidase inhibitors (2002-12-03),

15. 6426342 - Use of &bgr;-lactamase inhibitors as neuroprotectants (2002-07-30),

Title: Gary A Koppel - Pioneering Inventor from Indianapolis

Introduction: Gary A Koppel is a distinguished inventor based in Indianapolis, IN, known for his groundbreaking contributions to various fields.

Latest Patents: Gary A Koppel holds several patents in the areas of technology and healthcare, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: With a career spanning over two decades, Gary A Koppel has consistently pushed the boundaries of innovation, with his inventions making a significant impact in their respective industries.

Collaborations: Throughout his career, Gary A Koppel has collaborated with leading companies, research institutions, and universities to bring his inventions to life, further solidifying his reputation as a visionary inventor.

Conclusion: Gary A Koppel's passion for innovation and his relentless drive to create have cemented his legacy as a pioneering inventor, inspiring future generations to think outside the box and pursue their inventive ideas.